BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Beach

  Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 11, 2023

  Travere Therapeutics, Inc. announced that on May 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 46,000 shares of its common stock.

  May 11, 2023

   · 

  1 min read
• Business

  SomaLogic Reports First Quarter 2023 Financial Results

  SomaLogic, Inc., a leader in proteomics technology, today reported financial results for the quarter ended March 31, 2023.

  May 11, 2023

   · 

  10 min read
• Business

  Eiger BioPharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

  Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis delta virus (HDV) and other serious diseases, today reported financial results for first quarter 2023 and provided a business update.

  May 11, 2023

   · 

  8 min read
• Business

  Accelerate Diagnostics Reports First Quarter 2023 Financial Results

  Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023.

  May 11, 2023

   · 

  11 min read
• Business

  Trevi Therapeutics Announces First Quarter 2023 Financial Results and Provides Business Update

  Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced financial results for the quarter ended March 31, 2023, as well as provided business updates.

  May 11, 2023

   · 

  8 min read
• Business

  Biodesix Announces First Quarter 2023 Results and Highlights

  Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the first quarter ended March 31, 2023 and provided a corporate update.

  May 11, 2023

   · 

  8 min read
• Pharm Country

  Legend Biotech Announces Participation in Upcoming May 2023 Investor Conference

  Legend Biotech Corporation, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, announced it will participate in the 2023 RBC Capital Markets Global Healthcare Conference in New York City.

  May 11, 2023

   · 

  1 min read
• Business

  Lineage Cell Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

  Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX) today reported financial and operating results for the first quarter ended March 31, 2023 and will host a conference call today at 4:30 p.m. Eastern Time to discuss these results.

  May 11, 2023

   · 

  17 min read
• Business

  Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update

  Kezar Life Sciences, Inc. reported financial results for the first quarter ended March 31, 2023 and provided a business update.

  May 11, 2023

   · 

  10 min read
• Business

  Harrow Announces First Quarter 2023 Financial Results

  Harrow, a leading U.S. eyecare pharmaceutical company, announced results for the first quarter ended March 31, 2023.

  May 11, 2023

   · 

  13 min read